New Companies
Filter News
Found 3,510 articles
-
Cytena Founds Subsidiary in Taiwan
7/23/2019
Cytena Bioprocess Solutions is developing an innovative technology, which enables considerable reductions in time and increases in efficiency for cell line development.
-
P1vital announces launch of the Reward Task Optimisation Consortium - RTOC
7/22/2019
Research partners from pharma, academia, and SMEs have come together to form the Reward Task Optimisation Consortium.
-
This week has marked a number of stories over construction projects and real estate developers focused on the life sciences market. Here’s a look.
-
Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China
7/19/2019
Celltrion and Nan Fung Group announced the establishment of Vcell Healthcare Limited, a Joint Venture company between both parties.
-
Kronos Bio Snags $105 Million to Support Development of its Small Molecule Microarray Platform
7/18/2019
Since its launch, Kronos has demonstrated SMM’s potential to identify compounds that bind to target proteins directly or interfere at nanomolar potency with protein activity. -
Merry X-Ray Corporation Announces Strategic Shift to a Customer-Centric Focus As MXR The Imaging Solution Company
7/18/2019
Merry X-Ray Corporation, serving the medical diagnostic imaging market for over 60 years, announces a significant shift in their sales and marketing strategy, focusing all company resources on becoming a best in class customer-centric organization taking full advantage of their entire suite of product and service offerings.
-
CenExel Clinical Research Establishes Clinical Trial Centers of Excellence Company
7/18/2019
Unites Four of the Top US Clinical Research Facilities to Reduce Time and Cost for New Drug Development
-
Arie Belldegrun, founder and former chair, president and chief executive officer of Kite Pharma, has teamed up with real estate developer Tishman Speyer to launch a biotech-focused real estate company, Breakthrough Properties.
-
There’s been quite a few small and mid-sized deals announced today. Let’s take a look at four of them.
-
MIT's research enterprise in Singapore launches new research group, boosting nation's cell therapies R&D
7/15/2019
MIT's Research Enterprise in Singapore, SMART, launches a new research group, Critical Analytics for Manufacturing Personalized-Medicine (CAMP), as part of Singapore's National Cell Manufacturing Initiative to overcome scientific and technical challenges in life-changing cell therapies.
-
Clover Therapeutics, which sprung out of Clover Health, is supported by a number of biotech and pharma veterans, including Pfizer veteran Cheng Zhang, who is heading up therapeutics, and Genentech veteran Marcel van der Brug, who is the chief scientific officer for therapeutics.
-
Bayer Trendlines Ag Innovation Fund to Co-invest With Trendlines in New Company
7/10/2019
Novel technology licensed from the Weizmann Institute of Science for biological solutions to treat bacterial diseases in crops
-
Certara Announces the Formation of a New Practice Area Focused on Global Health
7/9/2019
Extensive global health drug development work inspired launch of Certara Global Health, to harness drug development innovation to improve the health of people worldwide
-
XLerateHealth Selects Six Healthcare Startups For First Accelerator Cohort in Flint, Michigan
7/9/2019
Women Lead Half the Start-Ups; Majority are Based in Michigan; All Commit to Improving Healthcare [09-July-2019] FLINT, Mich. , July 9, 2019 /PRNewswire/ -- XLerateHealth (XLH), an award-winning Louisville-based healthcare accelerator, today announced the selection of six startup companies to join the first bootcamp cohort of its accelerator in Flint, MI. XLH op
-
Help us identify the leading employers in the life science industry! We want to uncover who leads in key areas like diversity, culture, unique benefits and, of course, who are the 2019 Life Sciences Ideal Employers.
-
Evotec and Venture Capital Consortium Form 'breakpoint Therapeutics GmbH'
7/8/2019
Evotec SE announced the formation of Breakpoint Therapeutics GmbH, a spin-off company focusing on the development of Evotec's DNA damage response ("DDR") portfolio, comprising discovery-stage assets and drug targets that promise broad therapeutic application in a variety of cancers.
-
Simbec-Orion Announce Its New Unified Brand Offering
7/5/2019
Simbec-Orion, Europe’s leading full-service boutique CRO, announces its new unified brand offering comprising the divisions previously known as Simbec Research, Orion Clinical, Orion Santé and Seirian Laboratories.
-
BioSpace Movers and Shakers: July 3
7/3/2019
Biotech and pharma companies strengthen their executive leadership and board positions. -
BioSpace Global Roundup: July 3
7/3/2019
Companies from across the globe provide information on agreements and pipeline updates. -
Cambridge, Mass.-based Vaxess Technologies is inching closer to developing a bandage-like product that will be able to administer vaccines and other therapeutics through the skin.